These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21489417)

  • 21. Quality of life in people with severe mental illness. Reliability and validity of the Manchester Short Assessment of Quality of Life (MANSA).
    Björkman T; Svensson B
    Nord J Psychiatry; 2005; 59(4):302-6. PubMed ID: 16195135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric properties of the Disability Assessment Schedule (DAS) for behavior problems: an independent investigation.
    Tsakanikos E; Underwood L; Sturmey P; Bouras N; McCarthy J
    Res Dev Disabil; 2011; 32(2):653-8. PubMed ID: 21208774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.
    Orsel S; Akdemir A; Dağ I
    Compr Psychiatry; 2004; 45(1):57-61. PubMed ID: 14671738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and use of the functioning assessment short test in first psychotic episodes.
    González-Ortega I; Rosa A; Alberich S; Barbeito S; Vega P; Echeburúa E; Vieta E; González-Pinto A
    J Nerv Ment Dis; 2010 Nov; 198(11):836-40. PubMed ID: 21048476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis.
    Baron M; Schieir O; Hudson M; Steele R; Kolahi S; Berkson L; Couture F; Fitzcharles MA; Gagné M; Garfield B; Gutkowski A; Kang H; Kapusta M; Ligier S; Mathieu JP; Ménard H; Starr M; Stein M; Zummer M
    Arthritis Rheum; 2008 Mar; 59(3):382-90. PubMed ID: 18311751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.
    Müller MJ; Brening H; Gensch C; Klinga J; Kienzle B; Müller KM
    J Affect Disord; 2005 Sep; 88(1):69-74. PubMed ID: 16040126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prospective evaluation of the early course of schizophrenia in men and women after a first psychiatric hospitalization].
    Jaracz K; Górna K; Kiejda J; Rybakowski J
    Psychiatr Pol; 2008; 42(1):33-46. PubMed ID: 18567402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polish version of the Groningen Social Disabilities Schedule II (GSDS II)--assessment of validity].
    Sieradzki A; Kiejna A
    Psychiatr Pol; 2007; 41(6):779-87. PubMed ID: 18540421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical evaluation of the use of research tools in evaluating quality of life for people with schizophrenia.
    Hewitt J
    Int J Ment Health Nurs; 2007 Feb; 16(1):2-14. PubMed ID: 17229269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study on quality of life of patients of schizophrenia with and without depression.
    Dan A; Kumar S; Avasthi A; Grover S
    Psychiatry Res; 2011 Sep; 189(2):185-9. PubMed ID: 21453977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disability and quality of life in schizophrenia and obsessive compulsive disorder: a cross-sectional comparative study.
    Solanki RK; Singh P; Midha A; Chugh K; Swami MK
    East Asian Arch Psychiatry; 2010 Mar; 20(1):7-13. PubMed ID: 22351805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptation and validation of the Spanish version of the Strauss and Carpenter Prognostic Scale for Schizophrenia.
    Ahuir M; Bernardo M; de la Serna E; Ochoa S; Carlson J; Escartín G; Gutiérrez-Zotes A; Valero J; Salamero M; Cañizares S; Fernández-Egea E; Cañete J; Gallo P
    Rev Psiquiatr Salud Ment; 2009 Oct; 2(4):150-9. PubMed ID: 23034344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting changes following the provision of assistive devices: utility of the WHO-DAS II.
    Raggi A; Albanesi F; Gatti V; Andrich R; Leonardi M
    Int J Rehabil Res; 2010 Dec; 33(4):306-10. PubMed ID: 20421796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia.
    Guilera G; Gómez-Benito J; Pino O; Rojo JE; Cuesta MJ; Martínez-Arán A; Safont G; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Franco M; Rejas J
    Schizophr Res; 2012 Jul; 138(2-3):240-7. PubMed ID: 22521724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the 12-item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore.
    Abdin E; Seet V; Jeyagurunathan A; Tan SC; Mok YM; Verma S; Lee ES; Subramaniam M
    PLoS One; 2023; 18(11):e0294908. PubMed ID: 38033104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing cognitive-related disability in schizophrenia: Reliability, validity and underlying factors of the evaluation of cognitive processes involved in disability in schizophrenia scale.
    Passerieux C; Bulot V; Hardy-Baylé MC; Roux P
    Disabil Rehabil; 2018 Aug; 40(16):1953-1959. PubMed ID: 28395527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the World Health Organization Disability Assessment Schedule II using non-parametric item response models.
    Galindo-Garre F; Hidalgo MD; Guilera G; Pino O; Rojo JE; Gómez-Benito J
    Int J Methods Psychiatr Res; 2015 Mar; 24(1):1-10. PubMed ID: 25524862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The World Health Organization Short Disability Assessment Schedule (WHO DAS-S): a tool for the assessment of difficulties in selected areas of functioning of patients with mental disorders.
    Janca A; Kastrup M; Katschnig H; López-Ibor JJ; Mezzich JE; Sartorius N
    Soc Psychiatry Psychiatr Epidemiol; 1996 Nov; 31(6):349-54. PubMed ID: 8952375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary Validation of the World Health Organization Disability Assessment Schedule 2.0 for Mild Traumatic Brain Injury.
    Snell DL; Iverson GL; Panenka WJ; Silverberg ND
    J Neurotrauma; 2017 Dec; 34(23):3256-3261. PubMed ID: 28895491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.